Company & Sponsor Intelligence

Central South University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed3

Countries1

Therapeutic footprint

autismother_psychiatry

Indexed studies

NCT06362200The Validation and Biological Index Studies on the Improved Social Function of ASD by 40 Hz tACS
autism · ChinaNA

NCT02879110A 12-weeks Study to Evaluate Sulforaphane in Treatment of Autism Spectrum Disorder
autism · ChinaNA

NCT04481425Evaluation of the Efficacy of Non-drug Therapy (SMS Intervention) for Adolescents With NSSI
other_psychiatry · ChinaNA

Intelligence layer updated: 2026-10-15 06:14:04.252491+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →